POLISCOPE
Back to feed

The civic record

Read. Follow. Verify.

Lobbying Report: United States Anti-Doping Agency (Q2 2026)

Original title: ACG Advocacy → UNITED STATES ANTI-DOPING AGENCY (2nd Quarter Report 2026)

Record date · July 20, 2026

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

What This Bill Does

This report details activities conducted by ACG Advocacy on behalf of the United States Anti-Doping Agency during the second quarter of 2026. The firm focused on federal budget appropriations and anti-doping policy efforts.

Why it matters

This document discloses that the United States Anti-Doping Agency spent $40,000 on professional services to influence federal funding and drug control policies for the 2027 .

Who It Affects

Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.

Directly affected

United States Anti-Doping Agency

The agency is the client paying for lobbying services to influence federal budget and policy outcomes.

Directly affected

ACG Advocacy

The firm is the registrant receiving payment to perform lobbying activities on behalf of the client.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

What is the purpose of this document?
This is a mandatory quarterly disclosure report detailing the client, the amount paid, the issues lobbied, and the government agencies contacted.
How much did the United States Anti-Doping Agency spend on this lobbying firm?
The agency paid $40,000 to ACG Advocacy for services during the second quarter of 2026.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Lobbying Activity

ACG Advocacy

on behalf of UNITED STATES ANTI-DOPING AGENCY

2026

ALCOHOL AND DRUG ABUSEBUDGET/APPROPRIATIONS

“Anti-doping efforts.”

Senate LDAMatched on title words onlyView on LDA.gov →

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

financial connection100% confidence

Lobbying Expenditure

The United States Anti-Doping Agency utilized a specific lobbying firm to advocate for its 2027 fiscal budget across four major federal entities.

Connected Entities

Office of Natl Drug Control Policy, ACG Advocacy, Grace Bouton and 6 more
OrganizationOffice of Natl Drug Control Policy“Target of lobbying efforts.”Map →
OrganizationACG Advocacy“The lobbying firm representing the client.”Map →
PersonGrace Bouton“Lobbyist for ACG Advocacy.”Map →
OrganizationU.S. Senate“Target of lobbying efforts.”Map →
PersonShawn Smeallie“Lobbyist for ACG Advocacy.”Map →
OrganizationUnited States Anti-Doping Agency“The client organization seeking federal funding and policy support.”Map →
OrganizationOffice of Management & Budget“Target of lobbying efforts.”Map →
OrganizationU.S. House of Representatives“Target of lobbying efforts.”Map →
PersonJulie Philp“Lobbyist for ACG Advocacy.”Map →

Sources

Analysis Score

0–100
  • Significance40
    How much this matters to a regular citizen
  • Controversy10
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz10
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record